BDBM665033 US20240116892, Compound I-13

SMILES CN(C1CCN(CC1)c1cnc(NC(C)=O)cn1)C(=O)Nc1cc(C)cc(c1)C(F)(F)F

InChI Key InChIKey=LTXRPXJKLOFFIO-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 665033   

TargetTyrosine-protein kinase JAK2 [Y1007F,Y1008F](Human)
Ajax Therapeutics, Inc.

US Patent
LigandPNGBDBM665033(US20240116892, Compound I-13)
Affinity DataKd: <10nMAssay Description:JAK2 (JH1 domain-catalytic, Y1007F, Y1008F) kinase was expressed as N-terminal fusion to the DNA binding domain of NFkB in transiently transfected HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent